| DOXGX | VSPVX | DOXGX / VSPVX | |
| Total Expense Ratio | 0.41 | 0.05 | 820% |
| Annual Report Gross Expense Ratio | 0.46 | 0.05 | 920% |
| Fund Existence | 4 years | 12 years | - |
| Gain YTD | 11.622 | 12.405 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 123B | 7B | 1,757% |
| Annual Yield % from dividends | 1.13 | 1.65 | 68% |
| Returns for 1 year | 12.95 | 16.78 | 77% |
| Returns for 3 years | 128.06 | 48.04 | 267% |
| Returns for 5 years | N/A | 57.55 | - |
| Returns for 10 years | N/A | 148.21 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FPHAX | 35.63 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||
| FSAAX | 18.88 | N/A | N/A |
| Fidelity Advisor Asset Manager 60% A | |||
| SCVNX | 43.46 | N/A | N/A |
| Allspring Small Company Value Inst | |||
| WDSAX | 18.85 | N/A | N/A |
| Allspring Disciplined Small Cap A | |||
| ESCGX | 16.80 | N/A | N/A |
| Ashmore Emerging Markets Focus Eq C | |||